Search

Kathryn Doyle, a partner at Saul Ewing, will present during the Penn Medicine Commercialization Speaker Series. She will discuss the latest trends in Life Sciences intellectual property on November 17 from 12:00 - 1:00 p.m.

Allison Burdette, associate at Saul Ewing, will be presenting to the Children's Hospital of Los Angeles on October 12, 2022. She will focus on the topics of insight into regulatory/insurance litigations around compliance matters (i.e., Anti-kickback, Physician Self-Referrals, HIPAA, False Claims...

Washington, D.C.’s (D.C. or the District) Alcoholic Beverage Regulation Administration (ABRA) is now accepting applications for three new alcohol licenses that were created by the Reopen Washington D.C. Alcoholic Beverage Regulation Administration Amendment Act of 2022. We detail each of these...

Steve Malitz and Jamie Stevens of Saul Ewing's Chicago office spoke on " Rules, Insurance and Cost Cutting in Condominium Associations" for CAI in September 2022 with Brian Lozell of Associa.

In July 2022, Jamie Stevens, Counsel in Saul Ewing's Chicago Office and a member of the firm's Condominiums and Community Associations practice, spoke on “The Aftermath of New Fannie Mae Guidelines – Industry Updates, Deferred Maintenance, and Current Trends” for CAI with Anthony Dister of Wintrust...

​A new City of Chicago Ordinance requires that condominium associations and other highrise residential buildings provide relief for residents during extreme heat events. On June 22, 2022, in response to the heat-related deaths of residents of a senior living facility, the Chicago City Council...

Saul Ewing’s Condominium and Community Associations Practice is pleased to once again offer its annual summary of the Illinois Condominium Property Act ("ICPA"). 2020 and 2021 were years that no one will soon forget, with condominium associations scrambling to ensure resident safety in the midst of...

Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...